Source: Health Canada shortage reports · Updated Jul 16, 2026
Some Risperidone products are in shortage in Canada (17 of 81 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 7, 2026.
An antipsychotic used to treat schizophrenia and symptoms of bipolar disorder.
Products affected
17 / 81
In shortage since
May 17, 2017
Est. full return
Aug 7, 2026
Reports on file
225
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
APO-RISPERIDONE
0.50MG · TABLET · APOTEX INC
DIN 02282127 · since Jun 9, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
Active shortage
RISPERIDONE
0.5MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02533928 · since May 1, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
RISPERIDONE
0.25MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02533804 · since May 1, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
RISPERIDONE
4MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02533960 · since Aug 11, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
RISPERIDONE
2MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02533944 · since Jul 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
RISPERIDONE
1MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02533936 · since Jul 2, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
RISPERIDONE
1MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02533936 · since Jul 2, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TARO-RISPERIDONE
0.25MG · TABLET · SUN PHARMA CANADA INC
DIN 02328305 · since Mar 1, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TARO-RISPERIDONE
0.5MG · TABLET · SUN PHARMA CANADA INC
DIN 02328313 · since Feb 14, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TARO-RISPERIDONE
1MG · TABLET · SUN PHARMA CANADA INC
DIN 02328321 · since Sep 1, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TARO-RISPERIDONE
2MG · TABLET · SUN PHARMA CANADA INC
DIN 02328348 · since Sep 1, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TARO-RISPERIDONE
3MG · TABLET · SUN PHARMA CANADA INC
DIN 02328364 · since Sep 1, 2025, no end estimate · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Risperidone is currently affected by 17 active shortage reports filed with Health Canada by APOTEX INC, SIVEM PHARMACEUTICALS ULC, SUN PHARMA CANADA INC, JAMP PHARMA CORPORATION and 2 others.
The reported causes are: disruption of the manufacture of the drug; business reasons. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Risperidone is classified under “ANTIPSYCHOTICS” (ATC N05AX).
Recent changes
Jul 16, 2026
Estimated end date pushed back : Jul 31, 2026 → Aug 7, 2026
Jul 16, 2026
New report filed
Jul 16, 2026
New report filed
Jul 16, 2026
New report filed
Jul 16, 2026
New report filed
Jul 16, 2026
New report filed
Jul 16, 2026
New report filed
Common questions
What is Risperidone used for?
An antipsychotic used to treat schizophrenia and symptoms of bipolar disorder.
When will Risperidone be back in stock in Canada?
The latest manufacturer estimate is Aug 7, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Risperidone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Possible alternatives in the same class (antipsychotics)
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.